Personality and Drug Use (PDU)
NCT05180149 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2022-04-29
Summary
The study aims to assess whether the use of drugs relates to personality ratings. Specifically, we plan to investigate if people with different histories of substance use differentiate on personality assessments (current and past).
Conditions
- Personality
Sponsors & Collaborators
-
Maastricht University
collaborator OTHER -
Psychedelic Data Society
collaborator OTHER -
Quantified Citizen Technologies Inc.
lead INDUSTRY
Principal Investigators
-
Kim PC Kuypers, PhD · Maastricht University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-04-30
- Primary Completion
- 2023-04-30
- Completion
- 2023-04-30
More Related Trials
-
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
NCT05322954 ·Status: TERMINATED ·Phase: PHASE1
-
Influence of Medication on Functional Connectivity
NCT03612713 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Drug Effects on Interpersonal Interaction
NCT05123716 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Individual Differences in the Response to Drugs
NCT02485158 ·Status: COMPLETED ·Phase: NA
-
The Norwegian Addiction, Pain and Trauma Study
NCT04908410 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Stimulant Drugs on Social Perception
NCT03790618 ·Status: COMPLETED ·Phase: PHASE1
-
Does Serotonin System Stimulation Increase Pro-social Behavior? - A Comparative Pharmacological Neuroscientific Study in Healthy Humans
NCT06081179 ·Status: COMPLETED ·Phase: PHASE1
-
Prevalence of New Psychoactive Substances Use
NCT03695419 ·Status: UNKNOWN
-
Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment
NCT04343339 ·Status: COMPLETED
-
Study of the Opioid Modulation of the Effect of Alcohol on the Dopaminergic Reward System
NCT03854942 ·Status: TERMINATED ·Phase: PHASE1
-
Registration of Tobacco, Coffee and Substance Use Among Acutely Admitted Psychiatric Patients
NCT00184184 ·Status: COMPLETED
-
Cannabioids as a New Intervention for Amphetamine Dependence
NCT02952196 ·Status: WITHDRAWN ·Phase: PHASE2
-
Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]
NCT04178993 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Interactions With Risk of QT-prolongation in a General Hospital
NCT02043912 ·Status: COMPLETED
-
French Study on COgnitive Enhancement and Consumption of Psychoactive Substances Among Youth Students
NCT02954679 ·Status: COMPLETED
-
The Role of Dopamine, Reward Learning and Prefrontal Activity in Expectation-induced Mood Enhancement
NCT05208294 ·Status: COMPLETED ·Phase: NA
-
Dopamine and Opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity
NCT02557984 ·Status: COMPLETED ·Phase: NA
-
Neuromodulation and Cognitive Training in Opioid Use Disorder
NCT03773523 ·Status: RECRUITING ·Phase: NA
-
Ovarian Hormones and Stress Induced Drug Craving
NCT02098434 ·Status: COMPLETED ·Phase: NA
-
Activation of the Endocannabinoid System and Cognition
NCT05226351 ·Status: COMPLETED ·Phase: NA
-
MDMA-Assisted Therapy for Pathological Narcissism
NCT06565494 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Effects of Commonly Used Medications on Mood and Choice
NCT03652740 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Hallucinogens and Other Drugs on Mood and Performance
NCT02033707 ·Status: COMPLETED ·Phase: PHASE1
-
Characteristic of Drug Users Chronic Wound
NCT03608384 ·Status: COMPLETED
-
Endogenous Opioid Modulation by Ketamine
NCT03051945 ·Status: WITHDRAWN ·Phase: PHASE3